In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 26, No. 16 ( 2021-04-22)
Kurzfassung:
SARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B.1.351, generally comparable to non-VOC strain.
Materialart:
Online-Ressource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2021.26.16.2100413
Sprache:
Englisch
Verlag:
European Centre for Disease Control and Prevention (ECDC)
Publikationsdatum:
2021
ZDB Id:
2059112-3
